Literature DB >> 33183128

Telephone surveillance during the COVID-19 pandemic: Is it a helpful diagnostic tool for detecting acute pulmonary exacerbations in children with chronic lung disease?

Beste Ozsezen1, Nagehan Emiralioglu1, Dilber A Tural1, Birce Sunman1, Halime N Buyuksahin1, Ebru Yalcin1, Deniz Dogru1, Ugur Ozcelik1, Nural Kiper1.   

Abstract

INTRODUCTION: The global burden of the 2019 novel coronavirus disease pandemic on the healthcare system, as well as the high transmission risk of coronavirus disease has led to the use of alternative strategies for evaluation of children with chronic conditions. In this context, telemedicine has become the effective and affordable choice. In this study we aimed to evaluate the efficiency of telephone visits to determine pulmonary exacerbations and hospitalization rates of children with cystic fibrosis and interstitial lung disease.
METHODS: A total of 119 children with cystic fibrosis or interstitial lung disease were enrolled and provided cases in which telephone visits were applied during the peak time of the coronavirus disease pandemic in our country. The recordings of respiratory, gastrointestinal and other symptoms, nutrition status, rate of acute pulmonary exacerbation, treatments initiated by telephone visits, referral to hospital and hospitalization were established from the electronic health reports of the patients.
RESULTS: Thirteen patients (10.9%) were symptomatic, 12 of them (10%) were diagnosed with acute pulmonary exacerbation. One patient was diagnosed with peripheral facial paralysis. Nine patients were recalled to the hospital and seven patients (5.8%) were hospitalised. DISCUSSION: Using telemedicine the health status of patients can be defined, and patients can be guided on proper healthcare that they need, especially during the times of pandemics which we are facing. Communication with patients while minimising the risk of exposure to coronavirus disease is an important advantage of telemedicine. Telemedicine will have to be implemented on our daily medical practice in the near future.

Entities:  

Keywords:  COVID-19; Coronavirus; childhood; cystic fibrosis; interstitial lung disease; pandemic; pediatrics; pulmonary exacerbation; telehealth; telemedicine

Mesh:

Year:  2020        PMID: 33183128     DOI: 10.1177/1357633X20972008

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.344


  2 in total

1.  A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF.

Authors:  Stephanie Thee; Mirjam Stahl; Rainald Fischer; Sivagurunathan Sutharsan; Manfred Ballmann; Axel Müller; Daniel Lorenz; Dominika Urbanski-Rini; Franziska Püschner; Volker Eric Amelung; Carola Fuchs; Marcus Alexander Mall
Journal:  BMC Pulm Med       Date:  2021-04-21       Impact factor: 3.317

2.  Telemedicine solutions for clinical care delivery during COVID-19 pandemic: A scoping review.

Authors:  Raheleh Ganjali; Mahdie Jajroudi; Azam Kheirdoust; Ali Darroudi; Ashraf Alnattah
Journal:  Front Public Health       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.